MiNK Therapeutics, Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies

Other Names/Subsidiaries

  • AgenTus Therapeutics Inc.
See more in Biomedtracker

Latest on MiNK Therapeutics, Inc.

HBW Insight

FDA’s New Chief Counsel Robert Foster Brings Pandemic Response, Biotech Experience

 
• By Sue Sutter

Robert Foster, the US Food and Drug Administration’s new chief counsel, brings a background in COVID-19 pandemic response, legislative oversight and the biotech industry to the agency’s top legal post

Medtech Insight

New FDA Chief Counsel Robert Foster Has Senate, Biotech And Pandemic Response Experience

 
• By Sue Sutter

Robert Foster, the US Food and Drug Administration’s new chief counsel, brings a background in COVID-19 pandemic response, legislative oversight and the biotech industry to the agency’s top legal post

Pink Sheet

FDA’s New Chief Counsel Robert Foster Brings Pandemic Response, Biotech Experience

 
• By Sue Sutter

Robert Foster, the US Food and Drug Administration’s new chief counsel, brings a background in COVID-19 pandemic response, legislative oversight and the biotech industry to the agency’s top legal post

Scrip

Asia Deal Watch: Argo Partners RNAi Programs With Novartis In Major Biobucks Pact

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Novartis To Pay Argo $185m Up Fron